# Prospective Donor Specific Antibody (DSA) Monitoring Protocol

> **NCT01382355** · — · UNKNOWN · sponsor: **Providence Health & Services** · enrollment: 60 (estimated)

## Conditions studied

- Kidney Transplant
- Kidney/Pancreas Transplant

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01382355
- **Lead sponsor:** Providence Health & Services
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-08-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01382355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01382355, "Prospective Donor Specific Antibody (DSA) Monitoring Protocol". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01382355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*